6-Hydroxy-4'-tert-butyldimethylsylyl Raloxifene-d4
| Product Name | 6-Hydroxy-4'-tert-butyldimethylsylyl Raloxifene-d4 |
|---|---|
| Alternate Names | Raloxifene Stable Isotopes, Stable Isotopes of Raloxifene |
| CAT No. | CS-T-55772 |
| CAS No. | 1189422-34-1 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Raloxifene |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CC(C)(C)[Si](C)(C)OC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5 |
| Canonical Smiles | CC(C)(C)[Si](C)(C)OC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5 |
| InchIKey | YYSIXGNGLSNJGQ-KFESLDSXSA-N |
| Inchl | InChI=1S/C34H41NO4SSi/c1-34(2,3)41(4,5)39-28-16-11-25(12-17-28)33-31(29-18-13-26(36)23-30(29)40-33)32(37)24-9-14-27(15-10-24)38-22-21-35-19-7-6-8-20-35/h9-18,23,36H,6-8,19-22H2,1-5H3/i21D2,22D2 |
| IUPAC | [2-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-6-hydroxy-1-benzothiophen-3-yl]-[4-(1,1,2,2-tetradeuterio-2-piperidin-1-ylethoxy)phenyl]methanone |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
6-Hydroxy-4'-tert-butyldimethylsylyl Raloxifene-d4 is a deuterated analogue of the selective estrogen receptor modulator, Raloxifene. It is primarily used in pharmacokinetic and pharmacodynamic studies to gain a better understanding of the drug's metabolism and mode of action. The incorporation of deuterium into the molecule allows for more accurate measurement and tracking of the drug's behavior in biological systems.
Raloxifene, and its deuterated analogue, work by selectively binding to estrogen receptors in certain tissues, such as bone and breast tissue, while avoiding activation in other tissues, such as the uterus. This makes it a valuable tool in the prevention and treatment of osteoporosis and breast cancer.
Chemically, 6-Hydroxy-4'-tert-butyldimethylsylyl Raloxifene-d4 has a molecular formula of C30H36D4NO4Si and a molecular weight of 536.79 g/mol. It has a melting point of approximately 170-174°C and is soluble in organic solvents such as methanol and dimethyl sulfoxide.
Overall, 6-Hydroxy-4'-tert-butyldimethylsylyl Raloxifene-d4 is a useful compound for researchers studying the pharmacokinetics and pharmacodynamics of Raloxifene, as well as for those investigating the mechanisms of action of selective estrogen receptor modulators in general.
Get an Instant Quote
Related Compounds
Raloxifene-d4 6-Glucuronide | Raloxifene-d4 6-β-D-Glucuronide Lithium Salt | Raloxifene-d4 Bismethyl Ether | Raloxifene 4 Glucuronide D4 | Raloxifene D4 | Raloxifene D4 Hydrochloride |